Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
RESOURCE LINE
VACCINE
January/February 2007
Proposing compulsory HPV vaccination in preadolescent girls
Based on the Canada Communicable Disease Report (CCDR) Online publication 15 February 2007;33(ACS-2):1-32
National Advisory Committee on Immunization Statement on the Human Papillomavirus Vaccine: New Recommendations for Females 9 to 26 Years of Age
February 15, 2007
February - The recently approved human papillomavirus (HPV) quadrivalent vaccine protects against infection from HPV types 6, 11, 16 and 18. Its approval and recent recommendation for use in females 9 to 26 years of age was based on...
Based on the following published article: N Engl J Med 2007;356(2):125-34
Vascular Endothelial Growth Factor Antagonists in Advanced Renal Cell Carcinoma
Until recently, the cytokines interleukin-2 and interferon-alfa have been the only systemic treatments available for patients with advanced renal cell carcinoma (RCC). With few exceptions, neither treatment produced robust or durable...
2nd CSSAM / ISSAM North American Congress on the Aging Male
Enduring Implications of the Prostate Cancer Prevention Trial
Montreal, Quebec / February 8-10, 2007
Montreal - Given its ubiquitous but typically slow-growing nature, prostate cancer is considered an appropriate target for chemoprevention. The Prostate Cancer Prevention Trial (PCPT) confirmed the efficacy of the 5-alpha reductase...
48th Annual Meeting and Exposition of the American Society of Hematology
Chronic Lymphocytic Leukemia: Novel Algorithms in Early Disease
Orlando, Florida / December 9-12, 2006
Orlando - New data suggest that both treatments and treatment goals are evolving in chronic lymphocytic leukemia (CLL). While recent studies have associated new strategies with incremental improvements in anti-CLL activity, particularly a...
48th Annual Meeting and Exposition of the American Society of Hematology
Low Molecular-weight Heparins for High-risk Patients in Context of Clot Mechanisms
Orlando, Florida / December 9-12, 2006
Orlando - The multiple mechanisms that promote venous thromboembolism (VTE) in patients with acute illnesses or cancer has been the basis for considering broader indications for prophylaxis. In a new meta-analysis of studies, low...
48th Annual Meeting and Exposition of the American Society of Hematology
Improved Outcomes with Immunochemotherapy in Indolent and Related Lymphomas
Orlando, Florida / December 9-12, 2006
Orlando - A comparison of two consecutive studies in advanced follicular lymphoma showed that response rates, time to treatment failure and overall survival were significantly improved with...
48th Annual Meeting and Exposition of the American Society of Hematology
New Hope for Patients with Advanced, Resistant Cutaneous T-cell Lymphomas and Chronic Myeloid Leukemia
Orlando, Florida / December 9-12, 2006
Orlando - Cutaneous T-cell lymphomas (CTCLs) are rare tumours but when they become advanced, treatment options are limited. A novel treatment class, the histone deacetylase inhibitors, which includes vorinostat, have produced meaningful...
48th Annual Meeting and Exposition of the American Society of Hematology
Novel Agents Offer New Promise in Relapsed, Refractory Multiple Myeloma and Newly Diagnosed Disease
Orlando, Florida / December 9-12, 2006
Orlando - Novel agents that target pathways other than those affected by traditional chemotherapy agents are emerging as promising new options in second-line relapsed/refractory multiple myeloma (MM) as well as induction agents or as...